1. Home
  2. LNC vs RGEN Comparison

LNC vs RGEN Comparison

Compare LNC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lincoln National Corporation

LNC

Lincoln National Corporation

HOLD

Current Price

$41.67

Market Cap

8.5B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$150.76

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNC
RGEN
Founded
1905
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LNC
RGEN
Price
$41.67
$150.76
Analyst Decision
Hold
Buy
Analyst Count
12
11
Target Price
$45.92
$177.18
AVG Volume (30 Days)
1.7M
646.4K
Earning Date
02-12-2026
02-19-2026
Dividend Yield
4.33%
N/A
EPS Growth
626.01
N/A
EPS
11.17
0.03
Revenue
$18,426,000,000.00
$707,890,000.00
Revenue This Year
$6.91
$17.86
Revenue Next Year
$5.57
$12.44
P/E Ratio
$3.72
$4,837.83
Revenue Growth
35.24
11.74
52 Week Low
$27.58
$102.97
52 Week High
$46.82
$177.17

Technical Indicators

Market Signals
Indicator
LNC
RGEN
Relative Strength Index (RSI) 45.45 33.52
Support Level $40.73 $160.22
Resistance Level $42.08 $174.87
Average True Range (ATR) 1.07 7.03
MACD -0.04 -1.62
Stochastic Oscillator 63.57 2.98

Price Performance

Historical Comparison
LNC
RGEN

About LNC Lincoln National Corporation

Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability and dental.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: